Royalty Pharma Reports Second Quarter 2021 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/3/2026
- Wall St ends higher as stocks reclaim some shine
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Snowflake soars 20% on earnings beat and raised guidance
- Oil settles 1% higher, as US-Iran strikes threaten supplies
- Could Apple’s foldable iPhone be a $14B opportunity? Morgan Stanley weighs in
Royalty Pharma plc (RPRX) Reports Q2 Revenue of $555 Million
August 11, 2021 7:35 AM EDTRoyalty Pharma plc (NASDAQ: RPRX) reported Q2 revenue of $555 million, versus $511 million reported last year.
Increased 2021 guidance: Adjusted Cash Receipts(1) expected to be $2,080 to $2,120 millionFor earnings history and earnings-related data on Royalty Pharma plc (RPRX) click here.
... More